Neurodegenerative diseases–is metabolic deficiency the root cause?

VR Muddapu, SAP Dharshini… - Frontiers in …, 2020 - frontiersin.org
Neurodegenerative diseases, including Alzheimer, Parkinson, Huntington, and amyotrophic
lateral sclerosis, are a prominent class of neurological diseases currently without a cure …

Dopamine neuron systems in the brain: an update

A Björklund, SB Dunnett - Trends in neurosciences, 2007 - cell.com
The basic organization of the catecholamine-containing neuronal systems and their axonal
projections in the brain was initially worked out using classical histofluorescence techniques …

Mechanisms of neurotransmitter transport and drug inhibition in human VMAT2

S Pidathala, S Liao, Y Dai, X Li, C Long, CL Chang… - Nature, 2023 - nature.com
Monoamine neurotransmitters such as dopamine and serotonin control important brain
pathways, including movement, sleep, reward and mood. Dysfunction of monoaminergic …

Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines

Y Wang, P Zhang, Y Chao, Z Zhu, C Yang, Z Zhou, Y Li… - Cell research, 2024 - nature.com
Monoamine neurotransmitters such as serotonin and dopamine are loaded by vesicular
monoamine transporter 2 (VMAT2) into synaptic vesicles for storage and subsequent …

Complexity of dopamine metabolism

J Meiser, D Weindl, K Hiller - Cell Communication and Signaling, 2013 - Springer
Parkinson's disease (PD) coincides with a dramatic loss of dopaminergic neurons within the
substantia nigra. A key player in the loss of dopaminergic neurons is oxidative stress …

Transport and inhibition mechanisms of human VMAT2

D Wu, Q Chen, Z Yu, B Huang, J Zhao, Y Wang, J Su… - Nature, 2024 - nature.com
Abstract Vesicular monoamine transporter 2 (VMAT2) accumulates monoamines in
presynaptic vesicles for storage and exocytotic release, and has a vital role in …

Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.

JD Erickson, MK Schafer, TI Bonner, LE Eiden… - Proceedings of the …, 1996 - pnas.org
A second isoform of the human vesicular monoamine transporter (hVMAT) has been cloned
from a pheochromocytoma cDNA library. The contribution of the two transporter isoforms to …

Translational molecular imaging and drug development in Parkinson's disease

A Haider, NH Elghazawy, A Dawoud… - Molecular …, 2023 - Springer
Parkinson's disease (PD) is a progressive neurodegenerative disorder that primarily affects
elderly people and constitutes a major source of disability worldwide. Notably, the …

[BOG][B] The physiology of excitable cells

DJ Aidley - 1998 - books.google.com
This book provides the reader with an account of some of the experimental evidence on
which our present knowledge is based. The third edition of this highly successful book has …

Neurodegeneration and neuroprotection in Parkinson disease

S Fahn, D Sulzer - NeuroRx, 2004 - Elsevier
Many of the motoric features that define Parkinson disease (PD) result primarily from the loss
of the neuromelanin (NM)-containing dopamine (DA) neurons of the substantia nigra (SN) …